At the time of writing, Dexcom Inc [DXCM] stock is trading at $87.57, up 9.68%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DXCM shares have gain 5.51% over the last week, with a monthly amount glided 3.23%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on June 16, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $102. Previously, Goldman started tracking the stock with Buy rating on May 30, 2025, and set its price target to $104. On April 10, 2025, Mizuho initiated with a Outperform rating and assigned a price target of $85 on the stock. Redburn Atlantic upgraded its rating to a Buy and increased its price target to $115 on February 03, 2025. Robert W. Baird upgraded its rating to a Outperform and raised its price target to $104 on January 16, 2025. Robert W. Baird downgraded its rating to Neutral for this stock on July 26, 2024, and downed its price target to $80. In a note dated July 26, 2024, JP Morgan downgraded an Neutral rating on this stock and revised its target price from $145 to $75.
For the past year, the stock price of Dexcom Inc fluctuated between $57.52 and $117.19. Currently, Wall Street analysts expect the stock to reach $81.36 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $87.57 at the most recent close of the market. An investor can expect a potential drop of -7.09% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
According to Dexcom Inc [NASDAQ:DXCM], the company’s sales were 4.15B for trailing twelve months, which represents an 12.49% jump. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.18%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.24 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 81.87 points at the first support level, and at 76.18 for the second support level. However, for the 1st resistance point, the stock is sitting at 90.79, and for the 2nd resistance point, it is at 94.02.
Ratios To Look Out For
It is important to note that Dexcom Inc [NASDAQ:DXCM] has a current ratio of 1.50. In addition, the Quick Ratio stands at 1.32 and the Cash Ratio stands at 0.3. Considering the valuation of this stock, the price to sales ratio is 8.28, the price to book ratio is 15.15 and price to earnings (TTM) ratio is 65.74.
Transactions by insiders
Recent insider trading involved FOLETTA MARK G, Director, that happened on Jun 16 ’25 when 2750.0 shares were sold. EVP, Chief Legal Officer, Brown Michael Jon completed a deal on Jun 16 ’25 to sell 500.0 shares. Meanwhile, Director AUGUSTINOS NICHOLAS sold 3672.0 shares on Jun 16 ’25.
